Pharmaceutical manufacturers won a significant federal appeals court decision on 30 January in the ongoing legal dispute with the US Department of Health and Human Services regarding whether they can restrict 340B drug discounts to contract pharmacies.
The US Court of Appeals for the Third Circuit determined that the law governing the program does not support...






